Related Experiment Video
Updated: Apr 30, 2026
13:34
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
10.1K
Launching SMART 3D Cancer Models
Sam Ernst1,2,3, Olivier De Wever1,3
1Laboratory of Experimental Cancer Research, Department of Human Structure and Repair, Ghent University, Ghent, Belgium.
Cancer Research
|May 2, 2025
Summary
Researchers created "MatriSpheres," a novel 3D cancer model using decellularized ECM. This innovative approach better mimics in vivo tumor heterogeneity for improved cancer research and drug discovery.
Area of Science:
- Oncology
- Biomaterials Science
- Tissue Engineering
Background:
- The tumor microenvironment significantly influences tumor progression, but in vitro models struggle to replicate its complexity.
- Existing 2D and 3D culture systems often fail to capture native extracellular matrix (ECM) composition and cellular diversity.
Purpose of the Study:
- To develop a more physiologically relevant three-dimensional (3D) in vitro model for cancer research.
- To enhance the recapitulation of in vivo tumor heterogeneity using biomaterial-based scaffolds.
Main Methods:
- Integration of decellularized porcine-derived small intestinal submucosa ECM into monocellular spheroids.
- Formation of novel "MatriSpheres" designed to mimic native tumor structures.
Main Results:
- The developed MatriSpheres exhibited in vivo-like cancer cell heterogeneity.
- The use of decellularized ECM provided a beneficial scaffold for spheroid formation.
Conclusions:
- The MatriSphere model represents a significant advancement in 3D cancer modeling.
- Further development of Self-Matrix-Assembly to Recapitulate a Tumor (SMART) models holds promise for cancer research, drug discovery, and personalized medicine.
